GSK to acquire biopharmaceutical firm Affinivax in $3.3bn deal
Affinivax is engaged in developing a novel class of vaccines, including the advanced next-generation pneumococcal vaccines
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jun 22
Affinivax is engaged in developing a novel class of vaccines, including the advanced next-generation pneumococcal vaccines
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
16 May 22
Radicava ORS comes in a small, 5mL dose, with portable bottle, oral dosing syringe, and eliminates the need…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 May 22
The transaction also includes a strategic partnership to jointly develop and market Cullinan Oncology’s lead programme, CLN-081/TAS6417, an…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 May 22
The proposed deal includes the acquisition of Biohaven’s calcitonin gene-related peptide (CGRP) programme, including rimegepant, zavegepant and a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Apr 22
The regulatory submission of Pfizer and BioNTech is based on data from the Phase 2/3 clinical study of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Apr 22
In the second phase of the alliance, the university will expand its collaboration involvement to include all of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 Apr 22
Accupril is an ACE inhibitor used to treat high blood pressure (hypertension), in addition to management of heart…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Apr 22
The acquisition is said to enhance Samsung Bioepis’ business operations, advance its sales growth, improve operating margin, and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
20 Apr 22
With the acquisition, Regeneron will obtain Checkmate’s lead candidate vidutolimod, an investigational, advanced generation CpG-A oligodeoxynucleotide Toll-like receptor…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Apr 22
Antares’ commercial products and the current autoinjector expertise will help accelerate Halozyme’s approach to drive durable revenue growth…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates